Stock of the Day for January 25, 2026

Medline Stock Report

Medline
MDLN 90-day performance NASDAQ:MDLN Medline
Current Price
$46.31
+1.47 (+3.28%)
(As of 01/27/2026 04:00 PM ET)
30 Day Performance
10.26%
  
 
Market Capitalization
$60.84B
Price Target
$47.42

About Medline

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations. Its offerings typically include direct delivery, customized kit and procedure-packaging services, inventory management programs and value‑added services such as clinical education and operational consulting. These capabilities are aimed at improving clinical workflow and supporting large, complex supply networks.

Medline operates through an extensive distribution network and serves customers across multiple geographies, with a primary focus on North American healthcare markets alongside international sales and distribution activity. The company is run by an executive leadership team responsible for its commercial, operational and clinical service lines. As a company listed on the NASDAQ under the symbol MDLN, Medline positions itself as an integrated supplier and supply‑chain partner for the healthcare industry.

MDLN Company Calendar

JAN. 28, 2026
Today
DEC. 31, 2026
Fiscal Year End

Recent Medline News

Is It Time To Reassess Medline (MDLN) After Its Recent Share Price Climb
How the $7B Medline (MDLN) IPO Proves Fundamentals Are Back in Vogue
Medline sees RS rating climb to 77
Medline (NASDAQ:MDLN) Reaches New 1-Year High - Still a Buy?
Medline price target raised to $55 from $50 at BTIG
Jim Cramer Says Medline “Stock Is Unbelievable” And Recommends Buying It
Medline Industries: Solid Physical Moat With Visible Earnings Growth Runway
Medline's Quiet Period Set To Expire on January 26th (NASDAQ:MDLN)
This report was written by MarketBeat.com on January 25, 2026 and updated on January 28, 2026. This report first appeared on MarketBeat.com.